Article ; Online: COVID-19: Complement, Coagulation, and Collateral Damage.
Journal of immunology (Baltimore, Md. : 1950)
2020 Volume 205, Issue 6, Page(s) 1488–1495
Abstract: ... a summary of COVID-19 and review complement's role in COVID-19 acute respiratory distress syndrome and ... that the complement system plays a key role in this inflammatory reaction. Indeed, patients with severe COVID-19 show ... with complement inhibitors all recovered with no adverse reactions. These and other studies hint at complement's ...
Abstract | Coronavirus disease of 2019 (COVID-19) is a highly contagious respiratory infection that is caused by the severe acute respiratory syndrome coronavirus 2. Although most people are immunocompetent to the virus, a small group fail to mount an effective antiviral response and develop chronic infections that trigger hyperinflammation. This results in major complications, including acute respiratory distress syndrome, disseminated intravascular coagulation, and multiorgan failure, which all carry poor prognoses. Emerging evidence suggests that the complement system plays a key role in this inflammatory reaction. Indeed, patients with severe COVID-19 show prominent complement activation in their lung, skin, and sera, and those individuals who were treated with complement inhibitors all recovered with no adverse reactions. These and other studies hint at complement's therapeutic potential in these sequalae, and thus, to support drug development, in this review, we provide a summary of COVID-19 and review complement's role in COVID-19 acute respiratory distress syndrome and coagulopathy. |
---|---|
MeSH term(s) | Animals ; Betacoronavirus/immunology ; Blood Coagulation/drug effects ; Blood Coagulation Disorders/immunology ; Blood Coagulation Disorders/virology ; COVID-19 ; Complement Activation/drug effects ; Complement Activation/physiology ; Complement Inactivating Agents/therapeutic use ; Complement System Proteins/drug effects ; Coronavirus Infections/blood ; Coronavirus Infections/complications ; Coronavirus Infections/immunology ; Humans ; Inflammation/immunology ; Inflammation/virology ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/complications ; Pneumonia, Viral/immunology ; Respiratory Distress Syndrome/virology ; SARS-CoV-2 |
Chemical Substances | Complement Inactivating Agents ; Complement System Proteins (9007-36-7) |
Keywords | covid19 |
Language | English |
Publishing date | 2020-07-22 |
Publishing country | United States |
Document type | Journal Article ; Research Support, N.I.H., Extramural ; Review |
ZDB-ID | 3056-9 |
ISSN | 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381 |
ISSN (online) | 1550-6606 |
ISSN | 0022-1767 ; 1048-3233 ; 1047-7381 |
DOI | 10.4049/jimmunol.2000644 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ud II Zs.37: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MG 28: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.